Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer

Cancer Investigation

Volumn 31, Issue 9, 2013, Pages 607-615

  Cho, Hanbyoul ^a   Lee, You Sun ^a   Kim, Julie ^a,b   Chung, Joon Yong ^b   Kim, Jae Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biomarker; GLUT 1; Immunohistochemistry; Microarray; Ovarian cancer

Indexed keywords

GLUCOSE TRANSPORTER 1;

ARTICLE; CANCER PROGNOSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84887218455     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357907.2013.849722     Document Type: Article

References (24)

1. Jemal A, Siegel R,WardE,MurrayT, Xu J,ThunMJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57(1):43-66.
2. Cannistra SA. Cancer of the ovary. N Engl J Med 1993;329(21): 1550-1559.
3. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, Wingo PA, Howe HL, Anderson RN, Edwards BK. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004;101(1):3-27.
4. Warburg O. On the origin of cancer cells. Science 1956;123(3191): 309-314.
5. Isselbacher KJ. Sugar and amino acid transport by cells in culture-differences between normal and malignant cells. N Engl J Med 1972;286(17):929-933.
6. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novelmembers (review). MolMembr Biol 2001;18(4):247-256.
7. Airley RE, Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 2007;53(4):233-256.
8. Medina RA, Owen GI. Glucose transporters: expression, regulation and cancer. Biol Res. 2002;35(1):9-26.
9. Haber RS, Rathan A,Weiser KR, Pritsker A, Itzkowitz SH, Bodian C, Slater G, Weiss A, Burstein DE. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 1998;83(1):34-40.
10. Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Hunter R, Stratford I,West C. Glucose transporter glut-1 expression correlates with tumor hypoxia and predictsmetastasisfree survival in advanced carcinoma of the cervix. Clin Cancer Res. 2001;7(4):928-934.
11. Cantuaria G, Fagotti A, Ferrandina G,Magalhaes A, Nadji M, Angioli R, Penalver M, Mancuso S, Scambia G. GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy. Cancer. 2001;92(5):1144-1150.
12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25(4):402-408.
13. Shibusa T, Shijubo N, Abe S. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin Cancer Res. 1998;4(6):1483-1487.
14. Cho H, Kim JH. Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer. J Histochem Cytochem. 2009;57(5):513-521.
15. Mok SC, Elias KM, Wong KK, Ho K, Bonome T, Birrer MJ. Biomarker discovery in epithelial ovarian cancer by genomic approaches. Adv Cancer Res 2007;96:1-22.
16. Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J GynecolOncol 2012;23(4):265-273.
17. LiG,Miles A, Line A, Rees RC. Identification of tumour antigens by serological analysis of cDNA expression cloning. Cancer Immunol Immunother. 2004;53(3):139-143.
18. Raetz EA, Moos PJ. Impact of microarray technology in clinical oncology. Cancer Invest 2004;22(2):312-320.
19. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA,MaoM, Peterse HL, van der Kooy K,Marton MJ,Witteveen AT, Schreiber GJ, KerkhovenRM,Roberts C, LinsleyPS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415(6871):530-536.
20. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nucl Med 1996;37(6):1042-1047.
21. Cantuaria G, Magalhaes A, Penalver M, Angioli R, Braunschweiger P, Gomez-Marin O, Kanhoush R, Gomez-Fernandez C,Nadji M. Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary. Gynecol Oncol 2000;79(1):33-37.
22. DiSaia PJ, Creasman WT (eds. ). Clinical Gynecologic Oncology, 5th edition. St. Louis, MO: Mosby Year Book, 1997.
23. Semaan A, Munkarah AR, Arabi H, Bandyopadhyay S, Seward S, Kumar S, Qazi A, Hussein Y,Morris RT, Ali-Fehmi R. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction. Gynecol Oncol 2011;121(1):181-186.
24. Kim K, Park WY, Kim JY, Sol MY, Shin DH, Park do Y, Lee CH, Lee JH, Choi KU. Prognostic Relevance of the Expression of CA IX, GLUT-1, and VEGF in Ovarian Epithelial Cancers. Korean J Pathol 2012;46(6):532-540.